Physician profile
Ryan Jones
NPI 1003495169
$546.89
in general payments reported to CMS, 2019-2025
13 companies · $406 in 2025
The $406 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $141 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $546.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $107.65 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Mayne Pharma Commercial LLC | $72.59 | 2024-2025 | |
| Lilly USA, LLC | $52.66 | 2024-2025 | Zepbound, Mounjaro |
| Spr Therapeutics, INC | $47.97 | 2024 | Sprint Pns System |
| Astellas Pharma US INC | $46.88 | 2025 | Veozah, Vesicare |
| Bayer Healthcare Pharmaceuticals INC. | $40.42 | 2025 | |
| Organon LLC | $40.20 | 2024-2025 | Nexplanon |
| Astrazeneca Pharmaceuticals Lp | $33.00 | 2025 | Farxiga |
| Gilead Sciences, INC. | $26.86 | 2025 | |
| Sage Therapeutics, LLC | $22.69 | 2025 | Zurzuvae |
| Kowa Pharmaceuticals America, INC. | $20.63 | 2025 | Zoryve |
| Medtronic, INC. | $20.04 | 2024 | Intellis Adaptivestim |
| Pfizer INC. | $15.30 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.